Overview and benefits of port delivery device with ranibizumab

Video content above is prompted by the following:

• Can you provide an overview of the port delivery device with ranibizumab approved for treating neovascular AMD?
• How does the device function?
• What are the benefits of using the port delivery device with ranibizumab?
• Certainty of 6 months of continuous anti-VEGF delivery
• Patients in clinical trials prefer PDS over intravitreal injections

This post was originally published on this site